Showing results (1101-1110 of 1,341) with videos related to
Sort By:
Pageof 135
Neuro-Oncology Advances|May 2, 2023
Retrospective examination of pseudoprogression in IDH mutant gliomasEthan A Wetzel, Matthew J Farrell, Blaine S C Eldred, et al.Neuro-Oncology Advances|July 10, 2020
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapyRaymond Chang, Umberto Tosi, Julia Voronina, et al.Neuro-Oncology Advances|July 10, 2020
Prediction of recurrent glioblastoma after laser interstitial thermal therapy: The role of diffusion imagingAbdelkader Mahammedi, Suha Bachir, Edward J Escott, et al.Neuro-Oncology Advances|July 10, 2020
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapyMarica Eoli, Cristina Corbetta, Elena Anghileri, et al.Neuro-Oncology Advances|July 10, 2020
Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samplesSharon Berendsen, Elselien Frijlink, Jèrôme Kroonen, et al.Neuro-Oncology Advances|July 10, 2020
The invasive proteome of glioblastoma revealed by laser-capture microdissectionThomas Daubon, Joris Guyon, Anne-Aurélie Raymond, et al.Neuro-Oncology Advances|July 10, 2020
Brain tumors in Neurofibromatosis type 1Amanda De Andrade Costa, David H GutmannNeuro-Oncology Advances|July 10, 2020
Gliomas display distinct sex-based differential methylation patterns based on molecular subtypeMette L Johansen, L C Stetson, Vachan Vadmal, et al.Neuro-Oncology Advances|July 10, 2020
Constitutive activation of the EGFR-STAT1 axis increases proliferation of meningioma tumor cellsSara Ferluga, Daniele Baiz, David A Hilton, et al.Neuro-Oncology Advances|July 10, 2020
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapyZineb Belcaid, Cor Berrevoets, John Choi, et al.Pageof 135